Phase 3 Study to Compare Efficacy and Safety of DHP107 vs. Taxol® in Patients With Metastatic or Recurrent Gastric Cancer

Clinical trial NCT01839773 · COMPLETED

Trial details

NCT number: NCT01839773
Sponsor: Daehwa Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Stage IV Gastric Cancer

Start date: 2013-03-01
Primary completion: 2015-08-01
Enrollment: 238

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.